Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL31P26 refers to “ribosomal protein L31 pseudogene 26,” a *pseudogene* corresponding to the functional gene *RPL31*, which encodes a ribosomal protein that is part of the large 60S ribosomal subunit. Pseudogenes like RPL31P26 are non-functional genomic DNA sequences similar to normal genes but typically do not encode a functional protein due to mutations, truncations, or regulatory sequence loss. There is no evidence that RPL31P26 is transcribed or translated, nor are there known biological functions, disease associations, or drug interactions specific to this pseudogene[2][4][5][11][12][7][8]. Essential context: - The *parent gene* RPL31 is involved in basic cellular protein synthesis, and multiple pseudogenes have arisen from it throughout the genome[1][3][6]. - *Pseudogenes* are not therapeutically relevant targets as they generally lack transcription and translation, and they do not encode receptors, enzymes, transporters, or other druggable proteins[7][8]. - No molecular functions, disease roles, or drug associations are attributed to RPL31P26 specifically; any such information applies to the functional RPL31 gene, not to its pseudogenes. Summary: RPL31P26 is a *processed pseudogene* of the ribosomal protein L31 gene and is not a protein-coding or therapeutic target; it has no roles in disease, no associated drugs, and no established biological functions[2][4][5][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 26 (RPL31P26).